TenderlineUK
Procurement Intelligence
Search
Find a TenderAwarded without competitionContract details notice
Published 16 Sept 2025, 15:36 BST

Official UK procurement notice

Inherited Cancer Genetic Testing

Official notice

Procurement agent: Cardiff and Vale University Health Board

Direct award
Sectors: Health & Social Care (85) Delivery: Wales (UKL22)
Awarded value£450,000published award · exc. VAT
Awarded 3 Oct 2025no call for competition
Awarded to Informed Genetics

What is being bought

Published requirement description

This notice is to inform the public of a direct award for the provision of inherited cancer genetic testing services. The service is essential for the timely and accurate diagnosis of hereditary cancer syndromes, supporting clinical decision-making and patient care across NHS Wales. The contract has been awarded to a specialist provider with proven expertise and capability in delivering high-quality genetic testing aligned with national genomic standards. The award ensures continuity of service, compliance with clinical governance, and supports the strategic objectives of Genomics Partnership Wales.

The lotProcurement structure

single lot · no lot value published
Lot #1Awarded
Delivery: Wales
85148000 Medical analysis services

Procedure terms & legal framework

From the official record
Procedure method
Direct award
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Notice status
Awarded without competition
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Direct award (no call for competition)
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
16 Sept 2025, 15:36 BST
Last source update
3 Oct 2025, 14:36 BST
Authority reference
CAV-DCO (25-26) 85
FTS notice number
2025/S 000-062203
Latest notice
Contract details notice (UK7)
Delivery area
Wales (UKL22)
Official registry OCID
ocds-h6vhtk-059b82 Find a Tender
Why no open competition
Single Suppliers Technical Reasons
Published justification

The decision to proceed with a direct award to the current supplier is based on the supplier’s proven track record of delivering consistent, high-quality service and their deep understanding of our operational requirements. Maintaining continuity with the existing supplier ensures minimal disruption, preserves established workflows, and avoids the additional costs and risks associated with transitioning to a new provider. Furthermore, the supplier has demonstrated a strong commitment to partnership and continuous improvement, aligning well with our strategic objectives.

Review and risk notes
Risks

Changing suppliers at this stage presents several risks to contract performance, including potential service disruption, loss of operational continuity, and increased costs associated with onboarding a new provider. The current supplier has established familiarity with Cardiff and Vale university Health Board systems and processes, and replacing them could lead to delays, reduced efficiency, and quality issues during the transition period. Maintaining the existing relationship helps mitigate these risks and ensures consistent delivery aligned with organisational expectations.

Notice history

3 events · 2 releases on Find a Tender · since 16 Sept 2025
  1. Transparency notice published
    16 Sept 2025, 15:36 BST
    UK5
  2. Contract details notice published
    3 Oct 2025, 14:36 BST
    UK7
  3. Contract signature expected
    6 Oct 2025, 23:59 BST
    scheduled

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 1
Awarded value £450,0001 award exc. VAT
Contracts signed 1latest 3 Oct 2025
Awarded toValueDateStatus
Informed GeneticsInherited Cancer Genetics 1 Jan 2026 – 31 Dec 2026£450,000—Awarded

Contracts

  • Inherited Cancer Genetic Testing · Informed Genetics

    Signed
    3 Oct 2025
    Value
    £450,000
    Period
    1 Jan 2026 – 31 Dec 2026
    Status
    active

    No agreed KPIs: KPIs have not been established for this contract due to the highly specialised and clinically governed nature of inherited genetic testing, where performance is monitored through clinical standards rather than procurement metrics. The service is delivered by a limited number of expert providers, making standardised KPIs difficult to apply meaningfully. Additionally, the contract was developed in response to a specific clinical need, and procurement involvement was limited during specification, resulting in no formal KPIs being agreed at award stage

Contracting authority & participating public bodies

2 public bodies on the notice

NHS Wales Shared Services Partnership (hosted by Velindre University NHS Trust)

Procurement agent GB-PPON: PXWV-6492-CGMN 4-5 Charnwood Court, Cardiff, Wales, CF15 7QZContact email

Clients of the procurement agent

Bidders & participating suppliers

1 commercial party on the notice
  • Informed Genetics Awarded supplierGB-PPON: PZXY-1897-VDDJ Quinton Business Park , Birmingham , West Midlands, B32 1AFContact email

Official documents & specifications (3)

Official links; attachments are not copied

Tender pack and attachments

Notices published for this procedure

  • Contract details notice contractContract details noticeUK7Contract details notice on Find a Tender
  • Transparency notice awardTransparency noticeUK5Transparency notice on Find a Tender